Quantcast

Latest Novo Nordisk Stories

2014-04-03 12:30:42

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global and China Insulin Industry Report, 2013-2017 As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 382 million in 2013 at a compound annual growth rate of 7.6%. And insulin as the important diabetes medication has also seen increasing...

2014-04-02 16:30:25

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/37ktl3/global_and ) has announced the addition of the "Global and Chinese Insulin Industry Report - Forecasts to 2017" [http://www.researchandmarkets.com/research/37ktl3/global_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) As the third largest human health disease following neoplastic disease, cardiovascular and...

2014-03-28 04:21:53

BAGSVAERD, Denmark, March 28, 2014 /PRNewswire/ -- Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The 'Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow. To view the Multimedia News Release, please click:...

2014-03-27 12:29:54

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/h3fr9g/global ) has announced the addition of the "Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Strategy Diversification Divested: Productivity measurements, divestment of non-core assets resulting in healthy cash position. This will accelerate the next wave of targeted...

2014-03-27 08:34:26

Editor Note: For more information about this release, please scroll to bottom NEW YORK, March 27, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Novo Nordisk A/S (NYSE: NVO), HEALTHSOUTH Corp. (NYSE: HLS), Albany Molecular Research Inc. (NASDAQ: AMRI), Abiomed Inc. (NASDAQ: ABMD), and Geron Corporation (NASDAQ: GERN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are...

2014-03-24 23:24:35

MarketOptimizer.org offers “PharmaPoint: Type 2 Diabetes – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store. Dallas, Texas (PRWEB) March 24, 2014 This report focuses on type 2 diabetes pharmaceuticals in seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) and three emerging markets (China, India and Brazil). These 10 markets will be referred to as the global market. The global type 2 diabetes pharmaceutical markets in the 2012...

2014-03-14 08:28:02

DUBLIN, Mar. 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2msw4h/diabetes_herbal ) has announced the addition of the "Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Diabetes is a metabolic disorder arising mainly due to the fault in the...

2014-03-11 08:28:29

Patented technology could bring up to $167 million in milestone payments plus future long-term residual royalties to Caisson. OKLAHOMA CITY and AUSTIN, Texas, March 11, 2014 /PRNewswire/ -- Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, HEPtune(TM), announced today that it has expanded the scope of its partnership with global healthcare leader Novo Nordisk A/S (NYSE: NVO). This latest license agreement gives Novo Nordisk...

2014-03-10 12:26:21

New Jersey event brings hot-bed industry leaders to top-talent professionals ROOSEVELT, N.J., March 10, 2014 /PRNewswire/ -- HireLifeScience.com, the premier career networking website for the Life Science industries, will host its 5(th) annual career fair at The NJ Convention and Exposition Center at Raritan Center in Edison, NJ on September 30, 2014, sponsored by Novo Nordisk. This marks the first time that Novo Nordisk will present their open positions at the annual hiring...

2014-03-02 23:01:28

The foundation for the “Islamabad Call To Commitment and Action” was presented today at the concluding session of the Pakistan Diabetes Leadership Forum (PDLF). Islamabad, PK (PRWEB) March 02, 2014 The key points are the outcome of discussions and presentations by health practitioners and policy makers from Europe, Middle-East and Pakistan, who have over the past two days highlighted the alarming spread of diabetes in Pakistan and the urgency in improving diabetes care at both local...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related